Athersys Inc (@athersys) header
Athersys Inc (@athersys) profile picture

Committed to developing therapies to extend and enhance the quality of human life after stroke and other hard to treat diseases. https://nitter.cf/t.co/UThjHCM1Gj…

Cleveland, OH
Joined February 2011
We are excited to announce that Jane Wasman, JD, has been appointed Athersys Board Chair. Read more here: buff.ly/3F2IxB0
1
1
11
1,423
Tomorrow is our Annual Meeting of Stockholders. The meeting will begin at 8:30 a.m. ET. If you're a stockholder, please have your control number ready. Both stockholders and guests can join 15 minutes prior to the start of the meeting here: virtualshareholdermeeting.co…
3
9
941
The American Stroke Association has a number of great resources for stroke patients and caregivers, including a directory of local support groups. Find the support group nearest to you here: buff.ly/3LzV7LP
2
4
684
Following major injuries or systemic infections, the immune system may react in a harmful manner. Factors expressed by MultiStem cells have the potential to deliver therapeutic benefit in several ways, such as reducing acute inflammation while also promoting tissue repair. #ATHXfacts
6
17
1,960
Reminder: The interim analysis of the MASTERS-2 trial will determine whether the current proposed study size is still sufficiently powered to achieve statistical significance following the change in primary endpoint. We expect these results to be available in October. #MultiStem #celltherapy #clinicaltrials
7
2
18
2,446
Today we remember and honor all those affected by the events of 9/11.
2
7
728
We wish Sarah a great day at Massachusetts General Hospital as she speaks to their Department of Neurology on MultiStem Cell Therapy for the Treatment of Acute Neurological Indications! #MultiStem #CellTherapy #Neurology
1
3
13
1,624
On September 8th, Dr. Sarah Busch, Vice President of Regenerative Medicine and Head of Business Development, will be giving a seminar to Massachusetts General Hospital's Department of Neurology.
4
2
16
1,546
Our most advanced clinical program at Athersys is the MASTERS-2 Study, a Phase 3 trial for the treatment of acute ischemic #stroke. Learn how #MultiStem interacts with the human body when administered intravenously following a stroke. youtu.be/DxAUBEImf-k?si=3v3A…
4
1
15
1,738
ICYMI: We are hosting a business update conference call this Wednesday, August 9, at 4:30 p.m. ET. Register in advance here: conferencingportals.com/even…
3
1
6
877
Leslie tells her story of having a major stroke at the age of 33 and speaks to how important it is to know the signs and symptoms. #strokeawareness youtu.be/6xWgpjRAzmI
4
532